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Abstract
Background: Large variations in pain and function are seen over time in subjects at risk for and
with radiographic knee osteoarthritis (OA). We hypothesized that this variation may be related not
only to knee OA but also to patient characteristics. The objective of this study was to investigate
the influence of age, gender, and body mass index (BMI) on clinically relevant change in pain and
function over two years in subjects at high risk for or with knee OA.
Methods: We assessed 143 individuals (16% women, mean age 50 years [range 27–83]) twice; 14
and 16 years after isolated meniscectomy. Subjects completed one disease-specific questionnaire,
the Knee injury and Osteoarthritis Outcome Score (KOOS) and one generic measure, the SF-36.
Individuals with a BMI between 25 and 29.9 were considered overweight, while individuals with a
BMI of 30 or more were considered obese.
Results: Subjects aged 46–56 (the middle tertile) were more likely to change (≥10 points on a 0–
100 scale) in the KOOS subscale Activities of Daily Living (ADL) than younger subjects (odds ratio
[OR] 4.5, 95% confidence interval [95% CI] 1.5–13.0). Essentially the same result was obtained after
adjusting for baseline values. Overweight or obesity was a risk factor for clinically relevant change
for knee pain (OR 2.4, 95% CI 1.0 – 5.8, OR 4.0, 95% CI 1.2 – 13.6) and obesity for change in ADL
(OR 4.3, 95% CI 1.2 – 15.4). The results did not remain significant when adjusted for the respective
baseline value. Being symptomatic was strongly associated with increased variation in pain and
function while presence or absence of radiographic changes did not influence change over two
years in this cohort.
Conclusion: In a population highly enriched in early-stage and established knee OA, symptomatic,
middle-aged, and overweight or obese subjects were more likely to vary in their knee function and
pain over two years. The natural course of knee pain and function may be associated with subject
characteristics such as age and BMI.
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Background
The osteoarthritis (OA) disease process begins much ear-
lier than radiographic changes can be detected on plain
radiographs. Individuals with such incipient OA may rep-
resent an attractive target group for future therapy aimed
at slowing or stopping the further progression of OA. Indi-
viduals that have undergone meniscectomy constitute a
high risk group for development of knee OA, and may
represent a suitable group for studies on OA progression,
as well as clinical trials in OA [1-3]. In a previous study,
we investigated the natural variation in symptoms in a
cohort of patients who had undergone meniscectomy 14–
16 years earlier, and found that one in three patients
reported a clinically relevant change in pain and function
over two years [4]. Variability of symptoms in either direc-
tion is of interest to understand the natural course of knee
OA. We hypothesized that the natural variation of symp-
toms over time may not only depend on factors related to
the knee (such as the presence of joint pathology), but
also on factors not directly related to the knee, e.g. patient
characteristics such as age and weight. The objective of
this study was to investigate the influence of age, gender,
and body mass index (BMI) on clinically significant vari-
ation in pain and function over two years in subjects who
had undergone meniscectomy several years before. We
used a knee-specific instrument as the primary outcome
measure and a generic questionnaire as a secondary tool.
Methods
Patients
Approval was obtained from the Research Ethics Commit-
tee at the Faculty of Medicine, Lund University, Sweden.
All patients recruited were identified by searching the sur-
gical records at the Department of Orthopedics, Lund
University Hospital, Sweden [4]. A total of 552 subjects
had undergone meniscectomy between 1983 and 1985.
Inclusion and exclusion criteria allowed us to identify 264
patients who, in 1998, were sent self-administered ques-
tionnaires that assessed their knee-specific symptoms,
knee function, and general health status. Of those, 211
replied (response rate 80%). In 2000, follow-up question-
naires were distributed to 200 subjects (eleven subjects
were excluded because of death or newly-discovered co-
morbidity). Replies were received from 146 individuals
(73%). Three patients completed only one of two differ-
ent questionnaires. The remaining 143 patients (84%
men) formed the study group. Neither the baseline scores
nor patient characteristics for the non-responders differed
from the subjects completing the questionnaires at both
time points. Self-reported weight and height was obtained
from 141 of the patients at the second evaluation. Individ-
uals with a BMI between 25 and 29.9 were considered
overweight, while individuals with a BMI of 30 or more
were considered obese. The subjects' mean age at the first
follow-up was 50 (range 27–83) years. Assessments were
carried out with a median interval of 2.3 (range 2.3 to 3.0)
years.
Disease-specific questionnaire
The Knee injury and Osteoarthritis Outcome Score
(KOOS) Swedish version LK 1.0 was used [5]. KOOS is a
42-item self-administered knee-specific questionnaire
based on the WOMAC Osteoarthritis Index [6]. KOOS
was developed to be used for short- and long-term follow-
up studies of knee injuries, and it comprises five subscales:
Pain, other Symptoms, Activities of Daily Living (ADL),
Sports and Recreation Function, and knee-related Quality
of Life. A separate score ranging from 0–100, where 100
represents the best result, is calculated for each subscale.
The questionnaire and scoring manual are available from
the website http://www.koos.nu. The KOOS is valid and
reliable in follow-up of meniscectomy [5], anterior cruci-
ate ligament reconstruction [7] and total knee replace-
ment [8]. The patients completed the KOOS
questionnaire answering questions on their operated
knee.
Generic questionnaire
The 36-item Short Form (SF-36) of the Medical Outcome
Study, Swedish version was used [9]. The SF-36 is a self-
administered, generic measurement tool which has been
previously validated for use in the general populations
[10] as well as in selected populations with knee OA [11].
Responses to 35 of 36 questions are aggregated into eight
dimensions: Physical Function, Role-Physical, Role-Emo-
tional, Bodily Pain, Social Functioning, Mental Health,
Vitality, and perception of General Health. Responses vary
from dichotomous (yes/no) to a six-point verbal rating
scale. Results are calculated and presented as a profile of
scores of each of eight dimensions.
Clinically important variation
The minimal perceptible clinical improvement (MPCI)
represents the difference on the measurement scale asso-
ciated with the smallest change in the health status that
could be detected by the patient. Since the KOOS ques-
tionnaire contains the full and original version of the
WOMAC index and WOMAC scores can easily be calcu-
lated, we used the MPCI as described for the WOMAC
subscales pain, physical function, and stiffness [12].
According to this standard a level of 10 points or more on
a 0–100 scale was established as a cut-off representing a
clinically significant difference. We applied the same cut-
off for the generic SF-36 outcome measure as for the
KOOS.
Definition of a symptomatic index knee
Since there is no agreement upon a cut-off with regard to
'symptomatic' in this context, we used a previously
applied definition based on the patient's self-report fromHealth and Quality of Life Outcomes 2005, 3:59 http://www.hqlo.com/content/3/1/59
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the KOOS questionnaire [2]. This operational definition
aimed at identifying individuals symptomatic enough to
possibly seek medical care. The definition required that
the value of the KOOS subscale QOL and two out of the
four additional subscales should be equal to or less than
the score obtained as follows: At least 50% of the ques-
tions within the subscale were answered with at least one
step decrease from the best response (indicating no pain/
best possible function etc.) on a 5-point Likert scale. After
conversion to a 0–100 worst to best scale the cut-offs were
as follows: Pain ≤ 86.1, Symptoms ≤ 85.7, ADL ≤ 86.8,
Sport/Rec ≤ 85.0 and QOL ≤ 87.5.
Radiographic examination
One-hundred and thirty-three (93%) of the subjects had
undergone radiographic knee examination at the second
assessment. The radiographic technique and the grading
of radiographs have been detailed [3]. The cut-off for radi-
ographic OA corresponded to grade 2 or worse on the Kel-
lgren and Lawrence scale [13].
Statistics
Logistic regression models, both unadjusted and adjusted
for baseline values, were used to evaluate the association
of each study variable with clinically relevant change. The
logistic regression model included age divided into ter-
tiles, gender, and body mass index (categorized). The
odds ratio (OR) estimates with 95% confidence intervals
(95% CIs), and results from the likelihood ratio test,
expressed as P-values, were based on the models. We con-
sidered a P-value of 0.05 or less significant, and all tests
were two-sided (SPSS for Windows release 12.0.1, SPSS
Inc.). No prior sample size determination was made due
to the observational character of the present study. How-
ever, in a binomial post hoc power calculation, using
prevalence estimates and numbers from the existing data-
set (n = 143, clinical relevant change occurring in 8 of 50
subjects in the reference category, and at a significance
level of 0.05), we would have 80% power to detect an OR
of 3.16
Results
Age
There was an association of age 46–56 (middle tertile)
and clinically relevant change (≥10 points on a 0–100
scale) for the KOOS subscale ADL (OR 4.5, 95% CI 1.5 –
13.0) when unadjusted for baseline (figure 1, table 2), but
otherwise there were no significant associations detected
with respect to age. The association between the interme-
diate age tertile and ADL remained significant after adjust-
ing for baseline values, i.e., the subjects' ADL values from
1998 (table 2).
Variability in the subscale Activities of Daily Living of the Knee injury and Osteoarthritis Outcome Score (KOOS) over two  years Figure 1
Variability in the subscale Activities of Daily Living of the Knee injury and Osteoarthritis Outcome Score 
(KOOS) over two years. Subjects are divided into three groups (tertiles) according to their age. Each line represents one 
individual visualizing the difference between the score in 1998 (presented as zero, left endpoint of line) and in 2000 (right end-
point of the same line).
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Gender
No significant associations between gender and clinically
relevant change for pain or function were detected (tables
1, 2).
Body mass index
In a model unadjusted for baseline, overweight or obesity
was a risk factor for clinical variation in the knee-specific
subscale Pain (OR 2.4, 95% CI 1.0 – 5.8, OR 4.0, 95% CI
1.2 – 13.6), and obesity for change in ADL of the KOOS
questionnaire (OR 4.3, 95% CI 1.2 – 15.4). However,
when the baseline values were included in the model, the
associations did not remain significant (tables 1, 2). For
pain in general and Physical Function (SF-36), overweight
was associated with clinically relevant change (OR 2.2,
95% CI 1.0 – 4.8, OR 3.2, 95% CI 1.5 – 6.9) unadjusted
for baseline. The association remained for SF-36 Physical
Function after adjusting for baseline values, but not for
SF-36 Bodily Pain (tables 1, 2).
Radiographic knee OA
Fifty-eight of the 133 x-rayed subjects (44%) had radio-
graphic tibiofemoral or patellofemoral OA in their index
knee. In separate analyses (adjusted for age, gender, BMI,
and unadjusted and adjusted for baseline values, respec-
tively), we also evaluated the effect of radiographic knee
OA on clinically relevant change. We found no associa-
tion between the presence of radiographic OA (K/L grade
≥ 2) and clinical variation, neither in the knee-specific
KOOS nor the generic SF-36 subscales (p ≥ 0.09).
Symptomatic knee
In all the present analyses, the baseline values were highly
significant, where lower (worse) score was associated with
clinically relevant change (p ≤ 0.001).
According to our definition of a 'symptomatic' knee based
on the KOOS questionnaire, there were 61 individuals
who were symptomatic at entry and 66 who fulfilled the
same criteria at the second assessment. In a model
adjusted for age, gender, and BMI, the likelihood of clini-
cally relevant variation over time for subjects who were
symptomatic at baseline was significantly higher for all the
outcomes than subjects defined as asymptomatic: KOOS
Pain (OR 5.8, 95% CI 2.4 – 14.1), KOOS ADL (OR 4.5,
95% CI 1.9. – 11.0), SF-36 Bodily Pain (OR 3.0, 95% CI
1.3 – 6.8), and SF-36 Physical Function (OR 3.8, 95% CI
1.7 – 8.5).
Discussion
The present study indicates that being knee-symptomatic,
middle-aged, and overweight may predispose for varia-
tion in pain and function over two years. These factors are
therefore relevant to take into account when deciding
patient inclusion and exclusion criteria, outcome meas-
ures, and the number needed in clinical trials in subjects
with early-stage knee OA.
The Bristol 'OA 500' study is one of few studies on the nat-
ural variation of symptoms in knee OA [14]. In this
cohort, several baseline variables including age, gender,
and BMI were analyzed as possible predictors of change in
a combined index including change in pain, change in
Table 1: The effect of demographic characteristics on clinically relevant variation in pain over two years*
KOOS Pain SF-36 Bodily Pain
Characteristic Prevalence of 
clinically relevant 
change
Unadjusted 
for baseline 
values
Adjusted for baseline 
values
Prevalence of clinically 
relevant change
Unadjusted 
for baseline 
values
Adjusted for baseline 
value
N % OR OR 95% CI N % OR OR 95% CI
Age
<46† 11/49 22 27/49 55
46–56 17/47 36 1.5 1.1 0.4–3.1 32/47 68 1.2 1.1 0.4–2.8
>56 12/47 26 1.0 0.9 0.3–2.4 34/47 72 1.9 1.7 0.7–4.5
Gender
men† 35/120 29 78/120 65
women 5/23 22 1.2 0.5 0.2–1.8 15/23 65 1.2 1.1 0.4–3.2
BMI (kg/m2)
<25† 10/61 16 34/61 56
25–29.9 22/64 34 2.4 2.0 0.8–4.9 47/64 73 2.3 1.9 0.8–4.3
≥30 7/16 44 4.0 1.8 0.4–7.1 11/16 69 1.4 0.6 0.2–2.5
KOOS = Knee injury and Osteoarthritis Outcome Score, OR = odds ratio, 95% CI = 95% confidence interval, BMI = body mass index.
* All risk factors listed are entered simultaneously in each model.
† Reference category.Health and Quality of Life Outcomes 2005, 3:59 http://www.hqlo.com/content/3/1/59
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index joints, and global change. Neither age, gender, nor
BMI were shown to influence the variation over eight
years [14]. In comparison with our study subjects, the
Bristol 'OA 500' cohort was on average 10 years older,
held more women (69 vs. 16%), and included subjects
with OA not only of the knee but also of the hip and hand.
The mean BMI or presence of previous knee injuries was
not reported.
OA is usually studied in the elderly. However, it is well
recognized that OA may develop during middle-age or
earlier [15,16]. The age range of 27 to 83 for our cohort
allowed us to study the variation in symptoms in different
age categories. We found an increased variability in knee-
related function in patients aged 46–56, compared with
the younger age group. Younger subjects scored well at
entry, and in general their outcome remained good over
time. These age-related findings may reflect the develop-
mental phases of OA and correspond to an increase in the
report of knee disability seen in the population during
middle-age [16,17]. With increased age there may also be
large changes in lifestyle due to early retirement or other
alterations of the psychosocial situation that may affect
self-reported symptoms and knee function. The oldest
subgroup (aged >56) seem to form a more stable group
than the aged 46–56, but low subject numbers limit inter-
pretation of the results.
In analytic models unadjusted for baseline, overweight or
obesity was a predictor of clinically relevant variation in
outcome over two years. However, when adjusting for
baseline scores, these associations did not remain signifi-
cant. This is likely an effect of the strong association
between high BMI and being symptomatic. In a closely
related study we found no evidence that subjects had
become sedentary due to symptoms and then obese (as
cause and effect) [3].
Having a symptomatic knee, in comparison with having a
non-symptomatic knee, was strongly associated with large
variability over two years. We cannot exclude the contri-
bution of a ceiling effect, i.e., an individual with KOOS
Pain ≥ 91 cannot improve by 10 points. There was no
floor effect possible, as no study subjects had a score of 10
or worse. The finding of symptoms being a strong predic-
tor of change has less importance for future design in OA
trials since a common inclusion criterion is at least mod-
erate pain and functional limitations to be able to detect
a clinically relevant improvement from the intervention
applied.
We found no significant influence of radiographic status
on variation in pain and function in this cohort, consist-
ent with the well-known discordance between radio-
graphic status and pain in population-based studies of OA
[18,19].
We arbitrarily applied the same cut-off for clinically rele-
vant change for the generic SF-36 as for the knee-specific
measure KOOS. This serves as an important limitation in
interpreting the SF-36 results. The pain and function
subscales of the KOOS and SF-36 measures hold different
number of items, and the different items may have differ-
ent numbers of response options. A change in response of
Table 2: The effect of demographic characteristics on clinically relevant variation in function over two years
KOOS Activities of Daily Living SF-36 Physical Function
Characteristic Prevalence of clinically 
relevant change
Unadjusted 
for baseline 
values
Adjusted for baseline 
values
Prevalence of clinically 
relevant change
Unadjusted 
for baseline 
values
Adjusted for baseline 
value
N % OR OR 95% CI N % OR OR 95% CI
Age
<46† 6/49 12 21/49 43
46–56 19/47 40 4.5 3.8 1.2–12.4 24/45 53 1.2 0.9 0.3–2.4
>56 13/47 28 2.5 1.8 0.5–6.2 23/46 50 1.3 0.5 0.2–1.4
Gender
men† 32/120 27 54/118 46
women 6/23 26 1.2 0.7 0.2–2.3 14/22 64 2.4 1.9 0.6–6.1
BMI (kg/m2)
<25† 9/61 15 21/60 35
25–29.9 22/64 34 1.4 2.0 0.5–3.9 39/63 62 3.2 2.4 1.0–5.7
≥30 7/16 44 1.4 1.8 0.3–6.3 6/15 40 1.2 0.1 0.2–0.9
KOOS = Knee injury and Osteoarthritis Outcome Score, OR = odds ratio, 95% CI = 95% confidence interval, BMI = body mass index.
* All risk factors listed are entered simultaneously in each model.
† Reference category.Health and Quality of Life Outcomes 2005, 3:59 http://www.hqlo.com/content/3/1/59
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one step, e.g. from mild to moderate, will have greater
impact on the final score if the scale has fewer items, or
fewer response options. For the KOOS subscale Pain, a
one step change in response option will result in a score
change of 2.8 points. For the SF-36 subscale Bodily Pain
the corresponding change in response would yield a score
change of 6–20 points (depending on the item/response
option changed), explaining the larger proportion of
patients changing on the SF-36, compared with the
KOOS.
Other limitations of our study include low subject num-
bers and not taking into consideration several factors in
that may be important to the outcome studied, most
importantly medication, co-morbidities, educational
level, coping, and mood status. Also, the use of self-esti-
mates of weight and length from the second assessment
and the low proportion of women serve as limitations.
Meniscectomy is more frequently performed in men
[20,21], the reasons for which are not clear. We were una-
ble to evaluate the possible influence of "regression to the
mean" phenomenon as we only had data from two time
points. Strengths of our study include the use of validated
self-reported questionnaires which help avoid investiga-
tor bias, and the high follow-up rate of 73%.
Conclusion
In conclusion, we report that among a group highly
enriched in early-stage and established knee OA, symp-
toms at baseline, middle age, and overweight or obesity
are factors related to clinically relevant change in pain or
knee function over two years. Variation over time in knee
symptoms related to OA may thus also be dependent on
factors not directly related to the knee.
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